Predictive Factors for Successful Discontinuation of Continuous Renal Replacement Therapy: A Retrospective Single-Center Observational Study
DOI:
https://doi.org/10.61882/ijkd.3.03.8885Keywords:
Acute kidney injury, Continuous renal replacement therapy, Discontinuation criteria, Predictive factors, Intensive care unitAbstract
Introduction. Determining the optimal timing for discontinuing continuous renal replacement therapy (CRRT) in intensive care units (ICUs) remains a significant clinical challenge. This study aimed to identify the clinical and laboratory determinants of successful CRRT discontinuation in critically ill patients with acute kidney injury (AKI).
Methods. This retrospective, single-center observational study was conducted in Gülhane Training and Research Hospital, Ankara, Türkiye. A total of 396 patients who received CRRT between January 2019 and March 2023 were screened. After excluding patients with prior renal replacement therapy (RRT) (n = 66) and end-stage kidney disease (n = 250), 80 patients were included in the final analysis. Successful discontinuation was defined as independence from any RRT for at least seven consecutive days following CRRT cessation. Clinical variables were compared between the successful and unsuccessful groups.
Results. The mean age of the patients was 71.16 ± 14.96 years. In univariate analysis, successful discontinuation was significantly associated with higher 24-h urine output during CRRT [385 (0–3880) mL vs. 100 (0–1850) mL; P = .010], a stable or decreasing lactate trend in the first four hours (69% vs. 40%; P = .033), and a lower requirement for invasive mechanical ventilation (36.4% vs. 58.3%; P = .050). Receiver operating characteristic (ROC) curve analysis identified 24-h urine output as a significant predictor of success (Area under the curve (AUC) = 0.666; 95% Confidence interval (CI): 0.546–0.786; P = .011) with a threshold of 365 cc/24h (sensitivity: 52.3%, specificity: 80.6%). In the final logistic regression model, urine output in the last 24 hours remained an independent predictor of weaning success (Odds ratio (OR) = 1.001; 95% CI: 1.000–1.002; P = .009). Conclusion. The 24-h urine output preceding CRRT termination and the trend of lactate levels during the 4-hour period post-initiation are important predictive values for the success of CRRT discontinuation.
Downloads
References
1. Katayama S, Uchino S, Uji M, et al. Factors
predicting successful discontinuation of
continuous renal replacement therapy. Anaesth Intensive Care. 2016;44:453–457. https://doi.
org/10.1177/0310057X1604400401
2. Romero-González G, Lorenzin A, Neri M, et al. Discontinuation of Continuous Renal Replacement Therapy and Dialysis Dependence. Contrib Nephrol. 2018;194:118-125. https://doi.org/10.1159/000485609
3. Wang Y, Fang Y, Teng J, Ding, X. Acute Kidney Injury Epidemiology: From Recognition to Intervention. Contrib Nephrol. 2016;187:1-8. https://doi.org/10.1159/000443008
4. Baeg SI, Jeon J, Yoo H, et al. A Scoring Model with Simple Clinical Parameters to Predict Successful Discontinuation of Continuous Renal Replacement Therapy. Blood Purif. 2021;50(6):779-789. https://doi.org/10.1159/000512350
5. Li Y, Deng X, Feng J, et al. Predictors for short-term successful weaning from continuous renal replacement therapy: a systematic review and meta-analysis. Ren Fail. 2023 Dec;45(1):2176170. https://doi.org/10.1080/088602 2X.2023.2176170
6. Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purif. 2016;42(3):238-47. https://doi.
org/10.1159/000448507
7. Ricci Z, Ronco C. Dose and efficiency of renal replacement therapy: continuous renal re- placement therapy versus intermittent hemo- dialysis versus
slow extended daily dialysis. Crit Care Med. 2008
Apr;36(4 Suppl):S229– 37. https://doi.org/10.1097/
CCM. 0b013e318168e467
8. Lai TS, Shiao CC, Wang JJ, et al. Earlier versus later initiation of renal replacement therapy among critically
ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2017 Dec;7(1):38. https://doi.org/10.1186/s13613-017-0265-6
9. Wu VC, Ko WJ, Chang HW, et al. Risk factors of early redialysis after weaning from postoperative acute
renal replacement therapy. Intensive Care Med. 2008 Jan;34(1):101-8. https://doi.org/10.1007/s00134-007-0813-x
10. Katulka RJ, Al Saadon A, Sebastianski M, et al. Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT). Crit Care. 2020 Feb 13;24(1):50 https://doi.org/10.1186/s13054-020-2751-8
11. Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009 Sep;37(9):2576-82. https://doi.
org/10.1097/CCM.0b013e3181a38241
12. Khwaja, Arif. “KDIGO clinical practice guidelines for acute kidney injury.” Nephron Clinical Practice 120.4 (2012): c179-c184. https://doi.org/10.1159/000339789
13. Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in
the Intensive Care Unit. N Engl J Med. 2016 Jul
14;375(2):122-33. https://doi.org/10.1056/nejmoa1603017.
14. Yoshida T, Matsuura R, Komaru Y, et al. Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation. Nephrology (Carlton). 2019 Mar;24(3):287-293. https://doi. org/10.1111/nep.13396
15. Jeon J, Kim DH, Baeg SI, et al. Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Crit Care. 2018;22(1):255. https://doi. org/10.1186/s13054-018-2192-9
16. Hepokoski ML, Malhotra A, Singh P, et al. Ventilator-Induced Kidney Injury: Are Novel Biomarkers the Key
to Prevention? Nephron. 2018;140(2):90-93. https://doi. org/10.1159/000491557
17. Hepokoski M, Englert JA, Baron RM, et al. Ventilator-induced lung injury increases expression of endothelial inflammatory mediators in the kidney. Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F654-F660. https://doi. org/10.1152/ajprenal.00523.2016
18. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007 Sep;33(9):1563-70. https://doi.org/10.1007/s00134-007-0754-4
19. Gattas DJ, Rajbhandari D, Bradford C, et al. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults. Crit Care Med. 2015 Aug;43(8):1622-9. https://doi.org/10.1097/
CCM. 0000000000001004
20. RENAL Replacement Therapy Study Investigators.“Intensity of continuous renal-replacement therapy in critically ill patients.” New England Journal of Medicine 361.17 (2009): 1627-1638. http://doi.org/10.1056/NEJMoa0902413.
21. Guyette F, Suffoletto B, Castillo JL, Quintero J, Callaway C, Puyana, JC. Prehospital serum lactate as a predictor of outcomes in trauma patients: a retrospective observational study. J Trauma. 2011 Apr;70(4):782-6. https://doi.
org/10.1097/TA.0b013e318210f5c9
22. Veličković J, Palibrk I, Miličić B, et al. The association
of early postoperative lactate levels with morbidity after elective major abdominal surgery. Bosn J Basic Med Sci. 2019 Feb 12;19(1):72-80. https://doi.org/10.17305/bjbms.2018.3186
23. Kim SG, Lee J, Yun D, et al. Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury.BMC Nephrol. 2023 Jan 14;24(1):11.https://doi.org/10.1186/s12882-023-03063-y
Downloads
Published
Data Availability Statement
The data generated in this study are available from the corresponding author upon reasonable request.
